{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:49:33Z","timestamp":1792100973008,"version":"4.4.0"},"reference-count":214,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["P01CA275740"],"award-info":[{"award-number":["P01CA275740"]}]},{"award":["P01CA275740"],"award-info":[{"award-number":["P01CA275740"]}],"id":[{"id":"https:\/\/ror.org\/040gcmg81","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes, Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["R01DK107451"],"award-info":[{"award-number":["R01DK107451"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"award":["R01DK107451"],"award-info":[{"award-number":["R01DK107451"]}],"id":[{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Hepatocellular carcinoma (HCC) is undergoing a profound epidemiological shift from viral etiologies toward metabolic dysfunction-associated steatohepatitis (MASH). Current targeted therapies often fail to provide effective responses due to the complex, interconnected nature of the tumor microenvironment. This review aims to explain the molecular axis linking chronic metabolic injury to carcinogenesis, focusing specifically on the oncoproteins Astrocyte elevated gene-1\/metadherin (AEG-1\/MTDH) and staphylococcal nuclease and tudor domain-containing 1 (SND1) as cooperating regulators of this disease network. Methods: This article represents a narrative review of the published literature and does not follow a systematic or exhaustive search protocol. A structured literature search using specific search terms was conducted across PubMed, Scopus, and Web of Science databases, with a last search date of May 2026. Results: Available preclinical data indicate that AEG-1 mediates early preneoplastic injury via dysregulation of hepatic lipid metabolism leading to lipotoxicity and survival of genetically unstable hepatocytes. As the disease progresses, AEG-1 amplifies NF-\u03baB-driven inflammation and, as tumors emerge, recruits SND1 as a cooperating partner to form a gene-silencing complex that suppresses tumor suppressor proteins. Furthermore, AEG-1 and SND1 reprogram surrounding macrophages into an immunosuppressive state and drive tumor resistance to standard anti-angiogenic and chemotherapeutic drugs. Conclusions: The evidence reviewed supports a model in which HCC is driven by an interconnected metabolic-inflammatory-oncogenic cycle. AEG-1 functions as an upstream metabolic and inflammatory driver that cooperates with SND1 in a subset of oncogenic silencing events within this pathogenic network. Therefore, utilizing advanced nanomedicine platforms to simultaneously target these proteins represents a mechanistically rational therapeutic strategy that warrants further preclinical evaluation in advanced HCC.<\/jats:p>","DOI":"10.3390\/cancers18142335","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:09:09Z","timestamp":1784527749000},"page":"2335","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular Pathophysiology of Hepatocellular Carcinoma: From Metabolic Inflammation to Therapeutic Targets"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2204-5830","authenticated-orcid":false,"given":"Shady","family":"Azzam","sequence":"first","affiliation":[{"name":"Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2556-1584","authenticated-orcid":false,"given":"Alexandra","family":"Straus","sequence":"additional","affiliation":[{"name":"Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Senkal","sequence":"additional","affiliation":[{"name":"Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0973-2323","authenticated-orcid":false,"given":"Devanand","family":"Sarkar","sequence":"additional","affiliation":[{"name":"Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","article-title":"Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030","volume":"34","author":"Petrick","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and Management of Hepatocellular Carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of Hepatocellular Carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s12072-024-10692-4","article-title":"Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients","volume":"18","author":"Argenziano","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100231","DOI":"10.1016\/j.jhepr.2021.100231","article-title":"NAFLD and MAFLD as emerging causes of HCC: A populational study","volume":"3","author":"Myers","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: Risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"Stine","year":"2018","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/HEP.0000000000000786","article-title":"Molecular mechanisms in MASLD\/MASH-related HCC","volume":"82","author":"Wang","year":"2025","journal-title":"Hepatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MCG.0000000000001075","article-title":"Inadequate Hepatocellular Carcinoma Screening in Patients with Nonalcoholic Steatohepatitis Cirrhosis","volume":"53","author":"Aby","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Systematic Review and Meta-Analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated with Nonalcoholic Fatty Liver Disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/apt.16779","article-title":"Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: A retrospective cohort study","volume":"55","author":"Chong","year":"2022","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2021.06.012","article-title":"Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients with Cirrhosis","volume":"20","author":"Schoenberger","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1158\/1078-0432.CCR-20-3407","article-title":"FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma","volume":"27","author":"Casak","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2025.03.033","article-title":"Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC","volume":"83","author":"Rimassa","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1200\/JCO.20.03555","article-title":"Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients with Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I\/II Study","volume":"39","author":"Kelley","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_27","first-page":"EVIDoa2100070","article-title":"Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma","volume":"1","author":"Lau","year":"2022","journal-title":"N. Engl. J. Med. Evid."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e204564","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: The CheckMate 040 Randomized Clinical Trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2025.08.035","article-title":"Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration","volume":"84","author":"Lin","year":"2026","journal-title":"J. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-21-1258","article-title":"NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy","volume":"29","author":"Pinter","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"111194","DOI":"10.1016\/j.celrep.2022.111194","article-title":"S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway","volume":"40","author":"Sun","year":"2022","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1158\/0008-5472.CAN-21-0184","article-title":"EPHB2 Activates beta-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma","volume":"81","author":"Leung","year":"2021","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Facciorusso, A., Abd El Aziz, M.A., and Sacco, R. (2019). Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis. Cancers, 12.","DOI":"10.3390\/cancers12010036"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy","volume":"44","author":"Qin","year":"2024","journal-title":"Liver Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ccell.2025.01.001","article-title":"Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer","volume":"43","author":"Guo","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1038\/sj.onc.1205445","article-title":"Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH","volume":"21","author":"Su","year":"2002","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2005.04.006","article-title":"Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1","volume":"353","author":"Kang","year":"2005","journal-title":"Gene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1172\/JCI36460","article-title":"Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression","volume":"119","author":"Yoo","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17390","DOI":"10.1073\/pnas.0608386103","article-title":"Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-Then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1261\/rna.063313.117","article-title":"Oncoprotein AEG-1 is an endoplasmic reticulum RNA-binding protein whose interactome is enriched in organelle resident protein-encoding mRNAs","volume":"24","author":"Hsu","year":"2018","journal-title":"RNA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.01.008","article-title":"Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology","volume":"130","author":"Yoo","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.acr.2016.05.002","article-title":"AEG-1\/MTDH\/LYRIC: A Promiscuous Protein Partner Critical in Cancer, Obesity, and CNS Diseases","volume":"131","author":"Emdad","year":"2016","journal-title":"Adv. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature01956","article-title":"A micrococcal nuclease homologue in RNAi effector complexes","volume":"425","author":"Caudy","year":"2003","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.24216","article-title":"Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma","volume":"53","author":"Yoo","year":"2011","journal-title":"Hepatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-17-0298","article-title":"Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma","volume":"77","author":"Jariwala","year":"2017","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1093\/nar\/gkm470","article-title":"Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome","volume":"35","author":"Yang","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1038\/onc.2013.360","article-title":"The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells","volume":"33","author":"Cappellari","year":"2014","journal-title":"Oncogene"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1261\/rna.027656.111","article-title":"Tudor-SN and ADAR1 are components of cytoplasmic stress granules","volume":"18","author":"Weissbach","year":"2012","journal-title":"RNA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.febslet.2014.04.045","article-title":"Human Tudor staphylococcal nuclease (Tudor-SN) protein modulates the kinetics of AGTR1-3\u2032UTR granule formation","volume":"588","author":"Gao","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.febslet.2013.06.008","article-title":"Regulation of miR-17-92a cluster processing by the microRNA binding protein SND1","volume":"587","author":"Heinrich","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1210\/me.2002-0256","article-title":"Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5","volume":"17","author":"Paukku","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1093\/emboj\/cdf463","article-title":"Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II","volume":"21","author":"Yang","year":"2002","journal-title":"EMBO J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"14989","DOI":"10.1074\/jbc.M410465200","article-title":"The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6","volume":"280","author":"Valineva","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1128\/MCB.15.9.4735","article-title":"The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE","volume":"15","author":"Tong","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(00)80141-0","article-title":"Pim-1 kinase and p100 cooperate to enhance c-Myb activity","volume":"2","author":"Leverson","year":"1998","journal-title":"Mol. Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ccr.2014.04.027","article-title":"MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors","volume":"26","author":"Wan","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e186420","DOI":"10.1172\/JCI186420","article-title":"MASH: The nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.25868","article-title":"Astrocyte elevated gene-1 promotes hepatocarcinogenesis: Novel insights from a mouse model","volume":"56","author":"Srivastava","year":"2012","journal-title":"Hepatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.27339","article-title":"Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice","volume":"61","author":"Srivastava","year":"2015","journal-title":"Hepatology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1158\/0008-5472.CAN-14-1357","article-title":"Genetic deletion of AEG-1 prevents hepatocarcinogenesis","volume":"74","author":"Robertson","year":"2014","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1158\/1078-0432.CCR-11-1327","article-title":"Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition","volume":"17","author":"Zhu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hep.29230","article-title":"A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH)","volume":"66","author":"Srivastava","year":"2017","journal-title":"Hepatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acs.biochem.2c00583","article-title":"Astrocyte Elevated Gene-1 Cys75 S-Palmitoylation by ZDHHC6 Regulates Its Biological Activity","volume":"62","author":"Komaniecki","year":"2023","journal-title":"Biochemistry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1158\/0008-5472.CAN-14-0421","article-title":"AEG-1 regulates retinoid X receptor and inhibits retinoid signaling","volume":"74","author":"Srivastava","year":"2014","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep4.1834","article-title":"Dissecting the Balance Between Metabolic and Oncogenic Functions of Astrocyte-Elevated Gene-1\/Metadherin","volume":"6","author":"Rajesh","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0304-4165(00)00106-9","article-title":"Nuclear coactivator protein p100 is present in endoplasmic reticulum and lipid droplets of milk secreting cells","volume":"1523","author":"Keenan","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbalip.2006.05.005","article-title":"Overexpression of SND p102, a rat homologue of p100 coactivator, promotes the secretion of lipoprotein phospholipids in primary hepatocytes","volume":"1761","author":"Palacios","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bbalip.2016.05.011","article-title":"SND1 overexpression deregulates cholesterol homeostasis in hepatocellular carcinoma","volume":"1861","author":"Rueda","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_78","first-page":"137","article-title":"Channeling of newly synthesized fatty acids to cholesterol esterification limits triglyceride synthesis in SND1-overexpressing hepatoma cells","volume":"1864","author":"Chico","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"108181","DOI":"10.18632\/oncotarget.22569","article-title":"SREBP-2-driven transcriptional activation of human SND1 oncogene","volume":"8","author":"Armengol","year":"2017","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1096\/fj.201801253RR","article-title":"Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fba.2022-00115","article-title":"The RNA-binding protein Snd1\/Tudor-SN regulates hypoxia-responsive gene expression","volume":"5","author":"Saarikettu","year":"2023","journal-title":"FASEB Bioadv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1080\/21655979.2021.1974653","article-title":"Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice","volume":"12","author":"Zhao","year":"2021","journal-title":"Bioengineered"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0039-1681032","article-title":"Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis","volume":"39","author":"Maiers","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: From stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: Controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Tabas","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17061","DOI":"10.1038\/cddiscovery.2017.61","article-title":"HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses","volume":"3","author":"Nooka","year":"2017","journal-title":"Cell Death Discov."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1158\/0008-5472.CAN-18-0659","article-title":"Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis","volume":"78","author":"Robertson","year":"2018","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/15384101.2018.1557489","article-title":"Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosis","volume":"18","author":"Ding","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e013655","DOI":"10.1136\/jitc-2025-013655","article-title":"Macrophage Mtdh deficiency discordantly regulated tumor growth and metastasis through increased thrombospondin-1 production","volume":"14","author":"Jiang","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1080\/07391102.2025.2487697","article-title":"Elucidating the interaction between MTDH, an oncoprotein with UPR signalling molecule IRE1alpha under cellular stress","volume":"43","author":"Ramzan","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: A matter of life and death","volume":"15","author":"Schwabe","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1158\/0008-5472.CAN-07-6164","article-title":"Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1","volume":"68","author":"Sarkar","year":"2008","journal-title":"Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/0008-5472.CAN-05-3029","article-title":"Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis","volume":"66","author":"Emdad","year":"2006","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"ra79","DOI":"10.1126\/scisignal.2004496","article-title":"The endoplasmic reticulum acts as a platform for ubiquitylated components of nuclear factor kappaB signaling","volume":"6","author":"Alexia","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/sj.onc.1210713","article-title":"Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling","volume":"27","author":"Lee","year":"2008","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/ncomms7658","article-title":"Quantitative analysis of the TNF-alpha-induced phosphoproteome reveals AEG-1\/MTDH\/LYRIC as an IKKbeta substrate","volume":"6","author":"Krishnan","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ccr.2008.06.016","article-title":"Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis","volume":"14","author":"Sakurai","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/gutjnl-2021-324339","article-title":"Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny","volume":"71","author":"Sheng","year":"2022","journal-title":"Gut"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-kappaB and STAT3\u2014Key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"111101","DOI":"10.1016\/j.jbc.2025.111101","article-title":"Myeloid AEG-1\/MTDH drives inflammation and hepatocellular dysfunction in diet-induced steatohepatitis","volume":"302","author":"Raha","year":"2026","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1158\/0008-5472.CAN-14-0968","article-title":"Uncontrolled inflammation induced by AEG-1 promotes gastric cancer and poor prognosis","volume":"74","author":"Li","year":"2014","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/ecco-jcc\/jjab086","article-title":"MTDH Promotes Intestinal Inflammation by Positively Regulating TLR Signalling","volume":"15","author":"Wang","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Dewidar, B., Meyer, C., Dooley, S., and Meindl-Beinker, A.N. (2019). TGF-beta in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells, 8.","DOI":"10.3390\/cells8111419"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s10620-016-4075-8","article-title":"Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells","volume":"61","author":"Chen","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.fob.2014.03.012","article-title":"Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFbeta signaling","volume":"4","author":"Santhekadur","year":"2014","journal-title":"FEBS Open Bio"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/0008-5472.CAN-14-2387","article-title":"SND1 Acts Downstream of TGFbeta1 and Upstream of Smurf1 to Promote Breast Cancer Metastasis","volume":"75","author":"Yu","year":"2015","journal-title":"Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1038\/onc.2017.30","article-title":"SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFbeta1 response and breast cancer metastasis","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Sung, P.S., and Shin, E.C. (2021). Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020221"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"189623","DOI":"10.1016\/j.bbcan.2026.189623","article-title":"Targeting IL-17 family cytokines and receptors in hepatocellular carcinoma: From biology to combination immunotherapy","volume":"1881","author":"Pastwinska","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"215750","DOI":"10.1016\/j.canlet.2022.215750","article-title":"MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy","volume":"541","author":"Wan","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"218037","DOI":"10.1016\/j.canlet.2025.218037","article-title":"Oncoprotein SND1-enriched exosomes facilitate melanoma lung metastasis by regulating CD47-SIRPalpha-mediated macrophage reprogramming","volume":"634","author":"Chen","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Han, Q., Zhao, H., Jiang, Y., Yin, C., and Zhang, J. (2019). HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape. Cells, 8.","DOI":"10.3390\/cells8060558"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Li, X., Lei, Y., Wu, M., and Li, N. (2018). Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19102958"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41419-018-0534-9","article-title":"HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK\/ERK signalling pathway","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.gastro.2025.03.033","article-title":"Adipose Tissue Macrophages in Metabolic Dysfunction-Associated Steatohepatitis Secrete Extracellular Vesicles That Activate Liver Fibrosis in Obese Male Mice","volume":"169","author":"Rohm","year":"2025","journal-title":"Gastroenterology"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Yang, F., Chen, Y., Wang, Y., Zheng, G., Abouelnazar, F., Fan, L., Wang, Y., and Yan, Y. (2026). Lipotoxic hepatocyte-derived UBQLN1-enriched small extracellular vesicles activate hepatic stellate cells to promote hepatic fibrosis. Autophagy, 1\u201323.","DOI":"10.1080\/15548627.2026.2642976"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/21691401.2024.2360008","article-title":"Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease","volume":"52","author":"Li","year":"2024","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","article-title":"Wnt\/beta-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology","volume":"13","author":"Russell","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt-beta-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/hep.26924","article-title":"T-cell factor 4 and beta-catenin chromatin occupancies pattern zonal liver metabolism in mice","volume":"59","author":"Gougelet","year":"2014","journal-title":"Hepatology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/jhep.2001.23786","article-title":"Changes in WNT\/beta-catenin pathway during regulated growth in rat liver regeneration","volume":"33","author":"Monga","year":"2001","journal-title":"Hepatology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.21131","article-title":"Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice","volume":"43","author":"Sekine","year":"2006","journal-title":"Hepatology"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ncb1534","article-title":"Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia","volume":"9","author":"Kaidi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cmet.2013.11.023","article-title":"The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue","volume":"19","author":"Go","year":"2014","journal-title":"Cell Metab."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Cui, T., Wei, F., Zhou, Z., Sun, Y., Gao, C., Xu, X., and Zhang, H. (2024). Wnt\/beta-Catenin signaling pathway in hepatocellular carcinoma: Pathogenic role and therapeutic target. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1367364"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41418-018-0059-x","article-title":"Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt\/beta-catenin pathway","volume":"25","author":"Lo","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s11845-020-02199-2","article-title":"USP9X promotes the progression of hepatocellular carcinoma by regulating beta-catenin","volume":"189","author":"Chen","year":"2020","journal-title":"Ir. J. Med. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-024-07054-3","article-title":"Deep whole-genome analysis of 494 hepatocellular carcinomas","volume":"627","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"Beta-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/73448","article-title":"AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1","volume":"24","author":"Satoh","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","article-title":"Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas","volume":"21","author":"Taniguchi","year":"2002","journal-title":"Oncogene"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.gastro.2005.04.013","article-title":"Epidermal growth factor receptor: A novel target of the Wnt\/beta-catenin pathway in liver","volume":"129","author":"Tan","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.23538","article-title":"Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin","volume":"51","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"key":"ref_146","first-page":"1971","article-title":"Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin","volume":"62","author":"Harada","year":"2002","journal-title":"Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/0008-5472.CAN-03-2123","article-title":"Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations","volume":"64","author":"Harada","year":"2004","journal-title":"Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Tian, L.Y., Smit, D.J., and Jucker, M. (2023). The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032652"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2005.11.042","article-title":"PTEN function in normal and neoplastic growth","volume":"241","author":"Chow","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Trinh, V.H., Nguyen Huu, T., Sah, D.K., Choi, J.M., Yoon, H.J., Park, S.C., Jung, Y.S., and Lee, S.R. (2024). Redox Regulation of PTEN by Reactive Oxygen Species: Its Role in Physiological Processes. Antioxidants, 13.","DOI":"10.20944\/preprints202401.0356.v1"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res."},{"key":"ref_154","first-page":"95","article-title":"C-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis","volume":"9","author":"Gramlich","year":"1996","journal-title":"Mod. Pathol."},{"key":"ref_155","first-page":"866","article-title":"Amplification of the c-myc gene in human hepatocellular carcinoma: Biologic significance","volume":"92","author":"Peng","year":"1993","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.29183","article-title":"A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis","volume":"66","author":"Liu","year":"2017","journal-title":"Hepatology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.30697","article-title":"The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans","volume":"70","author":"Xu","year":"2019","journal-title":"Hepatology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1038\/onc.2009.223","article-title":"Nuclear LYRIC\/AEG-1 interacts with PLZF and relieves PLZF-mediated repression","volume":"28","author":"Thirkettle","year":"2009","journal-title":"Oncogene"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: Mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"21300","DOI":"10.1073\/pnas.0910936106","article-title":"Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis","volume":"106","author":"Emdad","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_161","first-page":"745","article-title":"AEG-1 is associated with hypoxia-induced hepatocellular carcinoma chemoresistance via regulating PI3K\/AKT\/HIF-1alpha\/MDR-1 pathway","volume":"15","author":"Xie","year":"2016","journal-title":"EXCLI J."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4161\/cbt.11.1.13835","article-title":"Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma","volume":"11","author":"Noch","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/cam4.1053","article-title":"HIF-1alpha binding to AEG-1 promoter induced upregulated AEG-1 expression associated with metastasis in ovarian cancer","volume":"6","author":"Zhao","year":"2017","journal-title":"Cancer Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"146446","DOI":"10.1016\/j.gene.2022.146446","article-title":"The absence of cellular glucose triggers oncogene AEG-1 that instigates VEGFC in HCC: A possible genetic root cause of angiogenesis","volume":"826","author":"Umapathy","year":"2022","journal-title":"Gene"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1074\/jbc.M111.321646","article-title":"Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221","volume":"287","author":"Santhekadur","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"152651","DOI":"10.1016\/j.bbrc.2025.152651","article-title":"Dietary short-chain fatty acid Sodium Butyrate orchestrates pro-apoptotic and anti-angiogenic pathways in HCC cells by targeting the novel SND1\/hTERT axis","volume":"784","author":"Charmanna","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/mol.116.107706","article-title":"Advances in Hypoxia-Mediated Mechanisms in Hepatocellular Carcinoma","volume":"92","author":"Xiong","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: Therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1038\/srep05524","article-title":"MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells","volume":"4","author":"Zhu","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Chakraborty, E., and Sarkar, D. (2022). Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers, 14.","DOI":"10.3390\/cancers14112798"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.cellsig.2014.01.026","article-title":"Upregulation of HIF-2alpha induced by sorafenib contributes to the resistance by activating the TGF-alpha\/EGFR pathway in hepatocellular carcinoma cells","volume":"26","author":"Zhao","year":"2014","journal-title":"Cell Signal."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm.4197","article-title":"Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases","volume":"22","author":"Frentzas","year":"2016","journal-title":"Nat. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"djw030","DOI":"10.1093\/jnci\/djw030","article-title":"Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma","volume":"108","author":"Kuczynski","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"102610","DOI":"10.1016\/j.ebiom.2019.102610","article-title":"The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma","volume":"51","author":"Xia","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1038\/onc.2015.7","article-title":"PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing beta-catenin expression and nuclear translocation","volume":"34","author":"Liu","year":"2015","journal-title":"Oncogene"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.28117","article-title":"Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade","volume":"62","author":"Guan","year":"2015","journal-title":"Hepatology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.canlet.2012.10.021","article-title":"Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth","volume":"329","author":"Dekervel","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389450122666210412125018","article-title":"Role of ATP-binding Cassette Transporters in Sorafenib Therapy for Hepatocellular Carcinoma: An Overview","volume":"23","author":"Estevinho","year":"2022","journal-title":"Curr. Drug Targets"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"101042","DOI":"10.1016\/j.drup.2023.101042","article-title":"Inhibition of NF-kappaB signaling unveils novel strategies to overcome drug resistance in cancers","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.0901451106","article-title":"Identification of genes conferring resistance to 5-fluorouracil","volume":"106","author":"Yoo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1158\/0008-5472.CAN-09-4009","article-title":"Molecular mechanism of chemoresistance by astrocyte elevated gene-1","volume":"70","author":"Yoo","year":"2010","journal-title":"Cancer Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2014.08.033","article-title":"Structural insights into the tumor-promoting function of the MTDH-SND1 complex","volume":"8","author":"Guo","year":"2014","journal-title":"Cell Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/1535-7163.MCT-20-0130","article-title":"Disruption of SND1-MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells In Vitro and In Vivo","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"12188","DOI":"10.1021\/acs.jmedchem.2c00862","article-title":"Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction","volume":"65","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/jacsau.3c00573","article-title":"Intracellular Delivery of Stabilized Peptide Blocking MTDH-SND1 Interaction for Breast Cancer Suppression","volume":"4","author":"Chen","year":"2024","journal-title":"JACS Au"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s43018-021-00280-y","article-title":"Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer","volume":"3","author":"Shen","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s43018-021-00279-5","article-title":"Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis","volume":"3","author":"Shen","year":"2022","journal-title":"Nat. Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acs.jmedchem.4c02574","article-title":"Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein-Protein Interaction","volume":"68","author":"Shen","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41419-024-07325-x","article-title":"TRAF2 and RIPK1 redundantly mediate classical NFkappaB signaling by TNFR1 and CD95-type death receptors","volume":"16","author":"Wagner","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/tcr.2017.04.01","article-title":"RIPK1-TRAF2 interplay on the TNF\/NF-kappaB signaling, cell death, and cancer development in the liver","volume":"6","author":"Yamamoto","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"629","DOI":"10.18632\/oncotarget.26602","article-title":"AEG-1 targeting for inhibiting inflammation: Potential anti-HCC strategy","volume":"10","author":"Reghupaty","year":"2019","journal-title":"Oncotarget"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/acs.bioconjchem.5b00254","article-title":"Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC)","volume":"26","author":"Rajasekaran","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/0008-5472.CAN-20-1876","article-title":"Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis","volume":"81","author":"Shen","year":"2021","journal-title":"Cancer Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ebiom.2015.06.020","article-title":"Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression","volume":"2","author":"Ventura","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1074\/jbc.M115.649707","article-title":"Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC)","volume":"290","author":"Srivastava","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/carcin\/bgz065","article-title":"Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-beta-catenin signaling pathway","volume":"41","author":"Zhu","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/gt.2008.60","article-title":"The size of endothelial fenestrae in human liver sinusoids: Implications for hepatocyte-directed gene transfer","volume":"15","author":"Wisse","year":"2008","journal-title":"Gene Ther."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41419-020-2571-4","article-title":"Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease","volume":"11","author":"Woitok","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/bc070116l","article-title":"Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery","volume":"18","author":"Zhang","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/mp400216r","article-title":"Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles","volume":"10","author":"Zhu","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.biochi.2012.10.029","article-title":"NF-kappaB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene","volume":"95","author":"Armengol","year":"2013","journal-title":"Biochimie"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Zhu, P., Mou, L., Lu, Y., Pu, Z., and Guo, C. (2025). Integrative single-cell and spatial transcriptomics analysis reveals FLAD1 as a regulator of the immune microenvironment in hepatocellular carcinoma. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1680101"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Qiao, W., Li, L., Jin, R., and Hu, C. (2025). Integrating single-cell RNA sequencing with spatial transcriptomics reveal the fibrosis-related genes in hepatocellular carcinoma. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1659404"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"107322","DOI":"10.1016\/j.jbc.2024.107322","article-title":"Spatial transcriptomics unravels palmitoylation and zonation-dependent gene regulation by AEG-1 in mouse liver","volume":"300","author":"Saverino","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Tao, Y., Wang, J., and Xu, X. (2020). Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.00184"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Shen, J., Wen, Y., Wu, S., and Tian, W. (2026). Integrating diagnosis and therapy in hepatocellular carcinoma: Advances in nanotheranostics. Front. Bioeng. Biotechnol., 14.","DOI":"10.3389\/fbioe.2026.1793834"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.mtbio.2022.100220","article-title":"Enhanced fluorescence\/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe","volume":"13","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/14\/2335\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:13:11Z","timestamp":1784693591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/14\/2335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":214,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cancers18142335"],"URL":"https:\/\/doi.org\/10.3390\/cancers18142335","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}